None of this explains why the VEHICLE performed so well at reducing inflammatory lesions?
- Forums
- ASX - By Stock
- BOT
- Ann: BTX 1503 Acne Phase 2 Study Results Presentation
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-27
-
- There are more pages in this discussion • 624 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.3¢ |
Change
0.003(0.66%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
38.0¢ | 38.5¢ | 38.0¢ | $258.5K | 676.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 272298 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.5¢ | 265193 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 273015 | 0.380 |
4 | 130925 | 0.375 |
6 | 168533 | 0.370 |
6 | 577604 | 0.365 |
10 | 504192 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.385 | 367044 | 11 |
0.390 | 815895 | 13 |
0.395 | 535169 | 12 |
0.400 | 763381 | 20 |
0.405 | 217450 | 7 |
Last trade - 10.01am 16/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online